Kawasaki Disease
Kawasaki Disease (KD) is a rare, COVID-related inflammatory illness that mainly affects children. It is characterized by fever, rash, conjunctivitis, and swollen lymph nodes. It is believed to be caused by an overactive immune system response to an infection, potentially triggered by the novel coronavirus.
KD is a serious illness that can lead to long-term complications if left untreated. The most common complication is inflammation of the coronary arteries, which can lead to an increased risk of heart attack or stroke. Other complications include joint pain, eye irritation, and skin rashes.
Diagnosis
KD is typically diagnosed through a combination of physical examination, laboratory tests, and imaging studies. The diagnosis is based on a combination of symptoms, physical exam findings, and laboratory results. A doctor may order lab tests to check for inflammation markers, such as C-reactive protein, and imaging studies, such as an echocardiogram or MRI, to look for signs of coronary artery involvement.
Treatment
Treatment for KD typically involves high doses of intravenous immunoglobulin (IVIG) and aspirin. IVIG is a medication made from donated human antibodies that helps reduce inflammation and prevent blood clots. Aspirin helps reduce inflammation and fever. Other treatments, such as corticosteroids and immune-suppressing medications, may also be used if necessary.
KD is a serious illness that requires prompt treatment to prevent long-term complications. If your child has symptoms of KD, it is important to contact your doctor right away.
